Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CIMDUO safely and effectively. See full prescribing information for CIMDUO. CIMDUO® (lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
CIMDUO® (lamivudine and tenofovir disoproxil fumarate) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg.
- generic_name
- lamivudine and tenofovir disoproxil fumarate
- product_names
- Lamivudine and Tenofovir Disoproxil Fumarate
- ndc
- 49502-450, 49502-450-93, 49502-450-77
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en